ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0774

The Impact of Patient/Provider Discordance on Changes on Mood and Behavior in Adolescents with Systemic Lupus Erythematosus

Zanab Mian1, Terrence Calistro2, Kimberly Rapoza2, Shari Berkowitz2, Tamar Rubinstein3, Kathleen Kenney-Riley2 and Joyce Hui-Yuen4, 1Cohen Children's Medical Center, New Hyde Park, NY, 2Mercy College, Dobbs Ferry, NY, 3Albert Einstein College of Medicine, White Plains, NY, 4Cohen Childrens Medical Center, New Hyde Park, NY

Meeting: ACR Convergence 2021

Keywords: depression, mood, Pediatric rheumatology, quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Pediatric Rheumatology – Clinical Poster II: SLE, JDM, & Juvenile Scleroderma (0764–0785)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Discordance between physicians’ and patients’ perceptions of disease severity can negatively impact treatment and disease outcomes; this has not yet been studied in children and adolescents with systemic lupus erythematosus (SLE). Neuropsychiatric symptoms, including depression and anxiety, can be present in up to 65% of adolescents with SLE. We propose to investigate the incidence of mood and behavioral changes, and its association with discordance between patient and physician perceptions of disease severity.

Methods: This is a multicenter pilot study conducted between September 2019 and April 2021. Patients over 12 years of age, diagnosed with SLE before their 19th birthdays, and who met ACR or SLICC Lupus classification criteria, were enrolled from two tertiary pediatric rheumatology centers in NY (one urban and one suburban). Data including demographics, disease manifestations, medications, and disease severity were collected. Patients completed standardized surveys assessing depression and various measures of quality of life. Global scores were obtained from individual patients and providers, analyzed via two-tailed t-tests, and compared with survey data using Pearson’s correlations. A p-value of < 0.05 was considered significant.

Results: A total of 58 patients were enrolled, 40 from the urban center and 18 from the suburban center. Overall, the mean age at enrollment was 19 (13-23) years, with 81% female. The two cohorts identified ethnicity and race as 47% Hispanic, 38% Black, 6% White, and 3% as Alaskan Native/American Indian. There were no differences between the two cohorts on administered Kidscreen-52, Adverse Childhood Experience, and most Promis-25 survey subsections specifically focused on psychosocial factors, fatigue, mood, and cognition. However, the suburban cohort demonstrated higher depression scores on CES-D (mean 24.05, p=0.008), indicative of severe depression, and higher emotional scores on PedsQL (mean 9.58, p=0.01). The overall mean patient global score was 3.0 (range 0-9), and physician global was 1.44 (range 0-7). Patient/physician discordance was noted to be higher in the urban-based institution (p=NS), possibly indicating that patient perception of disease was often more severe than provider assessment. Discordance was also associated with items from PedsQL school (r=0.41, p< 0.05) and PROMIS depression subsections (r=0.34, p< 0.05).

Conclusion: We found that pediatric SLE patients in an urban based center demonstrated higher patient/physician discordance when compared to a suburban cohort. However, adolescents with SLE demonstrated higher rates of depression and emotional changes at a suburban-based center, despite physician perception of stable disease.


Disclosures: Z. Mian, None; T. Calistro, None; K. Rapoza, National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), 5; S. Berkowitz, National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), 5; T. Rubinstein, None; K. Kenney-Riley, National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), 5; J. Hui-Yuen, None.

To cite this abstract in AMA style:

Mian Z, Calistro T, Rapoza K, Berkowitz S, Rubinstein T, Kenney-Riley K, Hui-Yuen J. The Impact of Patient/Provider Discordance on Changes on Mood and Behavior in Adolescents with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-impact-of-patient-provider-discordance-on-changes-on-mood-and-behavior-in-adolescents-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-patient-provider-discordance-on-changes-on-mood-and-behavior-in-adolescents-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology